October 19–20, 2021
Join the first virtual symposium on ex vivo T cell depletion in haploidentical stem cell transplantation organized by Stanford University. The event brings together clinicians, basic scientists, and translational investigators to discuss new advances and latest data on α/β+ T cell/CD19+ B cell and CD45RA+ T cell depletion strategies in the field of haploidentical HSCT. A board of international, renowned speakers will share their success stories in haploidentical stem cell transplantation using these transplant platforms for malignant and non-malignant indications.
We are pleased to support this international convention and are committed to advancing therapy by developing solutions for scalable clinical translation of novel cell and gene therapies. Discover our products and solutions below or get in touch with us for more information.
The innovative TCRα/β+ T cell depletion maintains γ/δ T cells, NK cells, and graft facilitating cells in the graft. The CliniMACS TCRα/β System allows for the automated T cell depletion by utilizing CliniMACS Prodigy® or CliniMACS Plus Instrument.
Watch the video to learn more.
Do you want to get in touch with us? Send your inquiry to:
Dr. Nikolas Kaltz